Search results

Jump to navigation Jump to search
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • ...s]] or suspensions; [[Platelet transfusion|platelets]] produced from whole blood or via apheresis; [[Fresh frozen plasma|plasma]]; and [[cryoprecipitate]]. ...to artificially produced substances and are thereby within the scope of ''blood substitutes''. ...
    2 KB (200 words) - 16:43, 3 January 2023
  • disease where the kidneys fail to adequately filter waste products from the blood
    13 statements, 0 sitelinks - 12:31, 14 February 2024
  • ...ing the release of a high concentration of protein metabolic wastes in the blood stream rapidly. ...n intake, pathological disorders lead to the accumulation of protein waste products, the no efficient metabolism of the proteins, or oligomerization of the ami ...
    16 KB (2,392 words) - 19:23, 25 February 2024
  • ...ing the release of a high concentration of protein metabolic wastes in the blood stream rapidly. ...n intake, pathological disorders lead to the accumulation of protein waste products, the no efficient metabolism of the proteins, or oligomerization of the ami ...
    17 KB (2,470 words) - 19:23, 25 February 2024
  • {{short description|Elimination by an organism of metabolic waste products}} ...h is part of the [[excretory system]]. In [[unicellular organism]]s, waste products are discharged directly through the surface of the cell. ...
    7 KB (935 words) - 12:20, 15 November 2023
  • ...de headache, nausea, and dizziness. Serious side effects may include [[low blood sugar]]. Use during [[pregnancy]] and [[breastfeeding]] is not recommended. ...tinal tract]] (GI) disturbances, occasional allergic reactions, and rarely blood production disorders including [[thrombocytopenia]], [[leukopenia]], and [[ ...
    7 KB (812 words) - 22:54, 13 March 2024
  • | products = [[:en:Moderna COVID-19 vaccine|Spikevax]]<br>[[Wikipedia:Vaccine|Vaccine] ...免疫療法]]の候補や、[[AstraZeneca]]との提携により、[[:en:myocardial ischemia|心筋虚血]]患者の[[:en:blood vessel|血管]]成長を促進する[[:en:vascular endothelial growth factor A|血管内皮増殖因子A]]をコー ...
    16 KB (841 words) - 11:23, 2 January 2024
  • ...de headache, nausea, and dizziness. Serious side effects may include [[low blood sugar]]. Use during [[pregnancy]] and [[breastfeeding]] is not recommended. ...tinal tract]] (GI) disturbances, occasional allergic reactions, and rarely blood production disorders including [[thrombocytopenia]], [[leukopenia]], and [[ ...
    7 KB (848 words) - 22:53, 13 March 2024
  • ...mal fat products such as [[lard]] or [[schmaltz]], fatty meats and [[dairy products]] made with whole or reduced fat milk like [[yogurt]], [[ice cream]], [[che ...(e.g., [[Palm kernel oil|palm kernel]], [[Coconut oil|coconut]]) and dairy products. The saturated fat in meat, [[egg (food)|eggs]], cacao, and [[nut (fruit)| ...
    14 KB (2,005 words) - 10:46, 10 May 2025
  • | products = [[#Products|See list of Johnson & Johnson products]] ****DePuy Synthes Products, Inc ...
    19 KB (1,255 words) - 12:24, 21 November 2023
  • * Elevated blood creatinine * [[Hypertension|High blood pressure]] ...
    8 KB (1,018 words) - 23:14, 12 April 2024
  • * Elevated blood creatinine * [[Hypertension|High blood pressure]] ...
    9 KB (1,056 words) - 23:14, 12 April 2024
  • ...の取り込みを減少させ、貯蔵[[triglyceride/ja|トリグリセリド]]の[[hydrolysis/ja|加水分解]]を増加させる。これは[[blood plasma/ja|血漿]]中の遊離[[fatty acid/ja|脂肪酸]]の上昇につながり、インスリン抵抗性をさらに悪化させる。インスリンは[[f 解釈は[[WHO/ja|WHO]]のガイドラインに基づく。2時間後の[[blood sugar/ja|血糖値]]が7.8 mmol/L(140 mg/dL)未満を正常、7.8~11. 0 mmol/L(140~197 mg/dL)を[ ...
    30 KB (665 words) - 09:52, 11 March 2024
  • ...synthesized]] pharmaceuticals, they include [[vaccine]]s, [[whole blood]], blood components, [[allergenic]]s, [[somatic cell]]s, [[gene therapy|gene therapi .../www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview |access-date=2017-05-15 |postscript=.}}</ref> Within EMA contexts, ...
    29 KB (3,642 words) - 16:31, 3 January 2023
  • ...r with dietary changes, they are used to treat [[hypertriglyceridemia|high blood triglycerides]] which may reduce the risk of [[pancreatitis]]. They are gen ...ot been tested in clinical trials as such drugs have. Prescription omega-3 products are more concentrated, requiring fewer softgels for the same daily dose. ...
    11 KB (1,574 words) - 22:14, 15 April 2024
  • ...r with dietary changes, they are used to treat [[hypertriglyceridemia|high blood triglycerides]] which may reduce the risk of [[pancreatitis]]. They are gen ...ot been tested in clinical trials as such drugs have. Prescription omega-3 products are more concentrated, requiring fewer softgels for the same daily dose. ...
    12 KB (1,634 words) - 22:13, 15 April 2024
  • ...ended as a tool for the pharmaceutical industry to classify pharmaceutical products (as opposed to their active ingredients).<ref>{{cite web|url=http://www.eph | [[Blood]] and [[haematopoiesis|blood forming organs]] ...
    14 KB (2,014 words) - 17:11, 3 January 2023
  • ...cid|HMB]], [[whey protein]], [[ZMA (supplement)|ZMA]], and [[weight loss]] products. Supplements are sold either as single ingredient preparations or in the fo ...om the U.S. [[Food and Drug Administration]] (FDA) before distributing the products. Since that time, manufacturers did not have to provide FDA with the eviden ...
    12 KB (1,685 words) - 08:24, 24 October 2023
  • | products = {{Unbulleted list|''[[Wikipedia:Call of Duty|Call of Duty]]'' series|''[[ ...lizzard Studios|Activision Blizzard Studios]]|Activision Blizzard Consumer Products Group}} ...
    41 KB (2,107 words) - 19:05, 4 January 2023
  • ...cid|HMB]], [[whey protein]], [[ZMA (supplement)|ZMA]], and [[weight loss]] products. Supplements are sold either as single ingredient preparations or in the fo ...om the U.S. [[Food and Drug Administration]] (FDA) before distributing the products. Since that time, manufacturers did not have to provide FDA with the eviden ...
    12 KB (1,743 words) - 08:12, 24 October 2023
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)